Wang et al. demonstrated that BRD4 inhibition suppressed Sonic hedgehog signaling to sensitize pancreatic ductal adenocarcinoma cells to gemcitabine [22]. Here, BRD4 is linked to pancreatic ductal adenocarcinoma.